Does knowing that the ridge thickness is decreasing using OCT after anti-VEGF for ROP value add to traditional clinical evaluation of resolving “plus” disease and regression of stage 3 as seen via indirect ophthalmoscopy? This evidence concerns the gene VEGFA and retinopathy of prematurity.